UK High Court Prevents Blogger From Claiming Defamation in Blog Post

August 31, 2009

The UK High Court recently held that a claimant, who was criticized in the comments section of his own blog, cannot sue for defamation, since he could have deleted the comment but failed to do so.

The case Carrie v. Tolkien [2009] EWHC 29 (QB) (15 Jan. 2009) relates to allegations of sexual abuse by Father Tolkein, the son of the famous author. 

The court pointed out that the plaintiff could have removed the offending comments posted on his own blog, which he saw four and a half hours after they first appeared but did not do so, and dismissed claims for defamation damages.

The plaintiff Carrie, is the author of a self-published book in which he claimed to have been sexually abused by Father John Tolkien, the son of writer JRR Tolkien. Carrie created a blog in 2007 and published a post under a pseudonym promoting his Web site and his book. Consequently JRR Tolkien’s great grandson, Royd Tolkien, posted a comment on the site claiming that Carrie was a fraud who was attempting to victimize the Tolkien family. Carrie wrote a denial of the comments but did not remove them.


Syrian Recognizes Unregistered Trademarks

August 31, 2009

According to our friends, the ag-IP-news agency, Syrian President Bashar Al-Assad has signed an amendment of Articles 44 and 45 of the 2007 Trademarks Law No. 8. According to the new Decree, the owner of well-known and distinctive trademarks in Syria, even those not registered, has the right to directly submit a request to the Ministry of Economy and Trade to strike off identical or similar marks and to prevent others from registering or using such marks for similar goods or services or even non-similar goods or services where the use of the mark may cause third parties to believe that there is a link between the owner of the well-known mark and such products, or where the mark could discredit the mark or cause damage to its owner.

Apparently, the Syrian Minister of Economy and Trade shall form an ad hoc committee to look into such requests within a month from the date of their submission.

When determining whether a mark is well-known, the issue is how well known the mark is to the target audience in Syria.

It is not clear how much relevance this development will have for our clientele as to register a mark in Syria, one has to declare that one does not trade with Israel.

This leads to all sorts of strange developments. In one of my less-effective networking moves, I found myself sitting next to a Syrian trademark attorney at lunch in an INTA event in London. Nothing Kosher to eat and little in the way of small talk…


The boy on Choco Containers to be phased out over 6 month period

August 30, 2009

 

The Jerusalem court has issued an interim decision, in which, based on  Israel Contract Law, Section 46 the judge has ruled that there is sufficient cause to believe that usage of Kroyotoro’s image was not in perpetuity, so now that the boy on the wrapping has objected to continued use of his image, Strauss should change the packaging.

It seems that there were arguably flaws in the contract, since it was not clear to the model that his image would be used for years and this eventuality was not taken into account when deciding on fair payment.

Since Strauss can afford any reasonable royalty if decided that it is appropriate to pay, the judge has ruled that they can continue to market the image for 6 months, to let stocks work their way through the system.

This is an interim decision only. Koryotoro, who is now a soldier, is claiming 5 million in damages.

There is no English language summary, but the case is 7901/09. The full reference is:

בשא 7901/09 רועי קרויטורו נ’ שטראוס גרופ בע”מ (מחוזי – י-ם, י’ שפירא) 20/08/2009
and may be found here: http://www.lawpubshop.co.il/CategoryID=266&ArticleID=458

In a similar case, model Russell Christoff won 15 million dollars from Nestle for using his image on Taster’s Choice Coffee internationally, when he had apparently only agreed for the image to be used in Canada.
See http://ipkitten.blogspot.com/2009/08/wake-up-and-smell-damages.html

The case is on appeal, and it may influence the eventual outcome of this case as well.

There are a number of famous images that have been used to sell the State of Israel.

The clean-shaven pioneer with sickle over his soldier is still alive and kicking, as are the soldiers that reached the Kotel in 1967. Indeed, the kid in the Warsaw Ghetto photo has been identified and survived the Holocaust. Did Herzl ever authorize the picture from the balcony in Basl and could his descendents object to it’s continued use without paying them?  Are we to face an international spate of lawsuits from the subjects of such photos who received no payment whatsoever?


USPTO Issues Guidelines About Patentable Subject Matter.

August 27, 2009

Preempting the US Supreme Court’s review of patentable inventions (re Bilski), the USPTO deputy commissioner has issued some nifty guidelines and rather inane flow-charts demonstrating to those requiring  intellectual examination what a machine is or what a transformation is.  See Dennis Crouch’s Patently-O:

http://www.patentlyo.com/patent/2009/08/interim-guidelines-on-statutory-subject-matter.html

From my reading of the guidelines, I would say that business methods and gene sequences are out in the interim. Note, this is interpretation only.  There are no clear statements to that effect. It does seem that anything new under the sun, is no longer patentable; merely new materials, new devices and systems and new methods of transforming matter.

I am not sure what the Supreme Court will do, but I assume that they are hearing the case as they intend to do something. It is, however, not clear why the USPTO has decided to publish interim guidelines.   

For a great piece of satire on the topic by Professor Jeremy Phillips, see the IPKAT: 

http://ipkitten.blogspot.com/2009/08/another-new-uspto-test.html


National Labor Court Rules on Patent Attorneys on Percentage Based Salaries

August 24, 2009

Judge AdlerJudge Steven Adler, President of the Israel Labor Court of Appeals has ruled on a dispute between a patent attorney and a firm employing the patent attorney on the basis of a percentage of billing. Whilst not rejecting the system out of hand, Adler was highly critical of it. 

Background

In Israel, a number of IP firms pay their patent attorneys a salary which is based on a percentage of the billing for their Read the rest of this entry »


Finjan get’s injunction against McAfee and $13.7 million in damages

August 23, 2009

In a 2006 lawsuit, Finjan accused Secure Computing of infringing patents for thwarting hostile downloads. In March 2008, a federal jury in Delaware awarded Finjan $9 million in damages. Secure Computing was bought in November 2008 by McAfee, which reported sales of $1.6 billion in 2008. 

The jury ruled that patents owned by Finjan, a company based in Netanya, Israel, were intentionally infringed, and according to an opinion by U.S. District Judge Gregory M. Sleet, Finjan has suffered irreparable harm and deserves Read the rest of this entry »


BBC Warns Tourists to Avoid Buying Fake Goods

August 23, 2009

Look-alike goods infringe trademark and design rights and may constitute passing off. often inferior to the brand named goods, sometimes, as with fake alcoholic beverages, creams and pharmaceuticals, the fake goods are dangerous to the consumer. The brand owner and tax loses significant sums to pirate manufacturers and distributors, and generally, worldwide, national  economies lose tax revenue.

In an interesting article found here: http://news.bbc.co.uk/2/hi/uk_news/8215519.stm 

the BBC warn tourists that some countries fine and imprison consumers of pirate goods and not only vendors.  

Be warned!


Floyd in the Pink over Nude Mark

August 23, 2009

nude skincare

The High Court has refused to grant an interim injunction to Nude Brands Limited (NBL) to prevent Stella McCartney Limited (SML) from launching an eau de toilette under the name STELLANUDE. NBL owns the registered word mark NUDE for a range of goods including cosmetics and perfumery, The judge, Floyd J considered that the likely damage to SML if an injunction were wrongly granted outweighed the damage to NBL if it were refused. The risk of irreparable harm occurring to NBL’s business or mark in the period until trial was considered fairly small for various reasons, including the fact that there was only a small risk of confusion between the parties’ respective products, and NBL had already licensed its mark for a range of products that were closer to its core skincare product than SML’s perfume product.

Stella McCartneyIn the words of Judge Floyd: “I have come to the conclusion that the balance of injustice in this case requires me to refuse the injunction. It seems to me that, in this particular case, the likely damage to SML and L’Oréal if an injunction is wrongly granted outweighs the damage to NBL if it is refused. Whilst NBL may ultimately prevail at the trial, it seems to me that an injunction and damages at that stage, though far from perfect as remedies, are more likely to be able to restore them to their rightful position than an award of damages under the cross undertaking to SML. The effect of an injunction wrongly granted against SML would be to cause a massive disruption to their business, and probably cause them to abandon use of the brand altogether. Against this I regard the likelihood of actual confusion between the products in the market place in the form in which they are currently presented as minimal. In coming to this conclusion I have not needed to attach any weight to an attack by SML on the ability of NBL to pay. Nevertheless, even though an offer to fortify the cross undertaking in damages by deposit of up to £1 million with NBL’s solicitors was made, I was not persuaded that if an injunction was granted, NBL’s asset position is such that the award of damages on the cross undertaking would provide full protection to SML and L’Oréal”.

The decision illustrates the difficulty of obtaining interim relief in the UK where there is no evidence that confusion will occur in the market place. Case: Nude Brands Limited v Stella McCartney Limited and others, 20 August 2009.


Serbian Court Jails Copyright Infringer

August 22, 2009

The Municipal Court of Nis, a town in southern Serbia, issued a three-month prison sentence and a nominal fine of approximately $US78 to an individual found to have infringed the Sony PlayStation copyright.

According to the court decision, the infringer sold pirated PlayStation games including Burnout: Revenge, Crash Tag Team Racing, FIFA Street 2, James Bond 007: NightFire, Medal of Honor: European Assault, Rainbow Six, Rayman Raving Rabbids, Resident Evil 4, Splinter Cell: Double Agent, and Spyro the Dragon.

The infringer also sold the following pirated films: A Little Princess, Aladdin, Cinderella, Happy Feet, Hoodwinked, Madagascar, Monster House, Pinocchio, Shrek, Shrek 2, the Simpsons, Sleeping Beauty, Speed Racer, Spiderman, Stuart Little 2, Thumbelina, Tokyo Godfathers, Tom and Jerry, Wallace and Gromit, The Adventures of Moby Dick, The Little Mermaid, The Mask of Zorro, and The Three Musketeers.

The pirated video games and films were sold for approximately EUR 1 per disc without permission of local authorized distributors.

The pirated items were confiscated and will be destroyed.

For the record, I have a personal interest in the case sinve I am a partner of JMB, Fa(c)tor & Co. which handles the Sony playstation trademarks in Israel.


Merck get’s Injunction preventing Teva from selling patented drug at risk

August 22, 2009

U.S. District Judge Garrett E. Brown Jr. of Trenton, New Jersey not only ruled that Teva had failed to show that the patent for Singulair was unenforceable and invalid but apparently declared the drug valid – which was a silly thing to do, as he should have declared the drug not shown to be invalid.

Singulair

The patent covers montelukast, the active ingredient in Singulair, Merck’s best-selling drug for treatment of asthma and allergies. The medicine that had 2008 sales of $4.3 billion. The medicine, approved by the U.S. Food and Drug Administration in 1998, is based on research that showed one way to treat the disease is to block leukotrienes, compounds that cause muscle contraction and increase secretions in the lungs.

Merck “put forth sufficient evidence of the failed attempts of others to develop a leukotriene antagonist,” Brown said in his opinion. Thus it appears that the non-obviousness of the approach was, according to the judge, based on secondary considerations such as long-felt need.  

Concurrently, the U.S. Patent and Trademark Office is reexamining the patent. Although the patent remains valid during reexamination proceedings, it is not clear that the patent will survive the scrutiny. If it does survive reexamination, the ruling will prevent Teva Pharmaceutical Industries Ltd (israel) from selling a generic version of the drug until August 2012.  If it doesn’t, Brown will realize that he was wrong for declaring a patent valid.

The case is Merck Sharp & Dohme Pharmaceuticals SRL v. Teva Pharmaceuticals USA, 07cv1596, U.S. District Court, District of New Jersey (Trenton).


Follow

Get every new post delivered to your Inbox.

Join 90 other followers